
Genetic Technologies Limited GENE
Annual report 2022
added 08-30-2022
Genetic Technologies Limited ROCE Ratio 2011-2026 | GENE
Annual ROCE Ratio Genetic Technologies Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -347.69 | -126.76 | -74.4 | -71.61 | -51.39 | -223.37 | -156.21 | -75.94 | 15.19 |
All numbers in AUD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 15.19 | -347.69 | -123.58 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M | ||
|
Bioventus
BVS
|
29.32 | $ 9.26 | 1.09 % | $ 617 M | ||
|
Biodesix
BDSX
|
-41.6 | $ 14.6 | -3.63 % | $ 1.89 B | ||
|
DarioHealth Corp.
DRIO
|
-36.38 | $ 8.45 | 9.74 % | $ 33.7 M | ||
|
DexCom
DXCM
|
33.2 | $ 66.09 | -1.12 % | $ 25.8 B | ||
|
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M | ||
|
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M | ||
|
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 103.08 | 3.09 % | $ 8.5 B | ||
|
IDEXX Laboratories
IDXX
|
61.76 | $ 573.29 | -0.42 % | $ 46.1 B | ||
|
Illumina
ILMN
|
-35.1 | $ 124.4 | -1.43 % | $ 19.8 B | ||
|
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
-47.68 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | ||
|
Medpace Holdings
MEDP
|
116.53 | $ 466.6 | -0.04 % | $ 13.5 B | ||
|
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | ||
|
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | ||
|
Myriad Genetics
MYGN
|
-105.22 | $ 4.62 | -1.28 % | $ 428 M | ||
|
National Research Corporation
NRC
|
161.47 | $ 17.52 | 1.98 % | $ 392 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | ||
|
Natera
NTRA
|
-76.66 | $ 196.15 | -0.62 % | $ 19.3 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
0.8 | $ 165.13 | -0.46 % | $ 8.18 B | ||
|
Organovo Holdings
ONVO
|
-120.24 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
4.4 | - | -16.95 % | $ 1.54 M | ||
|
OPKO Health
OPK
|
-7.58 | $ 1.17 | -1.68 % | $ 812 M | ||
|
Pacific Biosciences of California
PACB
|
-10354.48 | $ 1.35 | -2.88 % | $ 405 M | ||
|
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | ||
|
ENDRA Life Sciences
NDRA
|
-281.17 | $ 4.59 | 22.4 % | $ 2.46 M | ||
|
PerkinElmer
PKI
|
4.92 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | ||
|
Personalis
PSNL
|
-33.64 | $ 7.32 | -4.94 % | $ 434 M | ||
|
Interpace Biosciences
IDXG
|
-365.72 | $ 1.73 | 2.37 % | $ 7.59 M | ||
|
RadNet
RDNT
|
5.69 | $ 59.41 | -2.06 % | $ 4.47 B | ||
|
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
1.9 | - | - | $ 10.6 B | ||
|
Celcuity
CELC
|
-171.24 | $ 114.81 | 4.16 % | $ 4.53 B | ||
|
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | ||
|
Senseonics Holdings
SENS
|
-111.94 | $ 6.56 | -2.96 % | $ 274 M | ||
|
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 268.38 | 0.89 % | $ 22.3 B | ||
|
NeoGenomics
NEO
|
-9.11 | $ 7.76 | -0.13 % | $ 994 M | ||
|
Soleno Therapeutics
SLNO
|
2.09 | $ 31.83 | -0.03 % | $ 1.62 B | ||
|
Psychemedics Corporation
PMD
|
-43.78 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
-52.81 | $ 27.2 | -0.15 % | $ 35.3 M |